Watchlist Price Alert

Tandem Diabetes Care Inc. (TNDM)

NASDAQ: TNDM · Real-Time Price · USD

21.36

0.07 (0.33%)

At close: May 06, 2025, 3:59 PM

21.00

-1.66%

After-hours: May 06, 2025, 05:28 PM EDT

0.33% (1D)

Bid	21
Market Cap	1.42B
Revenue (ttm)	1.1B
Net Income (ttm)	-183.87M
EPS (ttm)	-2.79
PE Ratio (ttm)	-7.65
Forward PE	-32.53
Analyst	Buy

Ask	22.3
Volume	2,225,845
Avg. Volume (20D)	1,841,126
Open	21.14
Previous Close	21.29
Day's Range	21.13 - 22.24
52-Week Range	15.75 - 53.69
Beta	1.48

About TNDM

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technolo...

[Read more]

Industry Medical - Devices

Sector Healthcare

IPO Date Nov 14, 2013

Employees 2,650

Stock Exchange NASDAQ

Ticker Symbol TNDM

Website https://www.tandemdiabetes.com

Full Company Profile

Analyst Forecast

According to 15 analyst ratings, the average rating for TNDM stock is "Buy." The 12-month stock price forecast is $31, which is an increase of 45.17% from the latest price.

Stock Forecasts

Earnings Surprise

Tandem Diabetes Care has released their quartely earnings on Apr 30, 2025:

Revenue of $234.42M exceeds estimates by $14.2M, with 22.30% YoY growth.

EPS of -0.665 misses estimates by -0.06, with -3.91% YoY decline.

Why Price Moved

6 days ago

+18.58%

Tandem Diabetes shares are trading higher after th... Unlock content with Pro Subscription

2 weeks ago

-2.32%

Shares of diabetes stocks are trading lower following successful obesity data from Lilly.

News

5 days ago · zacks.com

TNDM Stock Rises Despite Q1 Earnings Miss, Gross Margin Up

Tandem Diabetes' Q1 bottom line lags estimate. However, the company experiences strong sales growth both in and outside the United States.

1 week ago · seekingalpha.com

Tandem Diabetes Care, Inc. (TNDM) Q1 2025 Earnings Conference Call Transcript

Tandem Diabetes Care, Inc. (NASDAQ:TNDM ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Company Participants Susan Morrison - EVP & Chief Administrative Officer John Sheridan - President ...

1 week ago · zacks.com

Tandem Diabetes Care (TNDM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Tandem Diabetes Care (TNDM) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with...

1 week ago · zacks.com

Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates

Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $0.60. This compares to loss of $0.63 per share a year ago.

1 week ago · zacks.com

What to Expect From These 3 MedTech Stocks This Earnings Season?

Here is a sneak peek into how these three MedTech stocks, ALGN, TNDM and ICLR, may fare in their quarterly results, slated to be released tomorrow.

2 weeks ago · zacks.com

Reasons to Hold TNDM Stock in Your Portfolio for Now

A robust diabetes market and international expansion raise investors' optimism for Tandem Diabetes.

3 weeks ago · zacks.com

Tap Into the Silver Economy Boom With These Aging Demographics Stocks

The global demographic shift is reshaping healthcare demand, driving long-term investment in pharmaceuticals, medical devices, home care and digital health.

3 weeks ago · fool.com

2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction

With equity markets reeling due to President Donald Trump's tariffs, many investors are taking this opportunity to buy shares of top companies on the dip. It's a great strategy, but it's essential to ...

3 weeks ago · zacks.com

Tandem Diabetes Care (TNDM) Moves 7.6% Higher: Will This Strength Last?

Tandem Diabetes Care (TNDM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the n...

1 month ago · businesswire.com

Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2025 results after the financial m...

Load More News